Table 2B.

Secondary Outcome Results

GAF
Baseline	70.00 [62.00–78.75]				65.00 [60.00–66.25]
Day 5	68.50 [61.25–78.75]	0.93	0.006	[0.006,1.00]	65.00 [61.75–66.25]	0.06	0.44	[0.19,1.00]
1 Month	63.00 [53.50–65.00]				68.00 [65.75–72.50]
MADRS
Baseline	6.00 [4.25–15.25]				5.50 [3.75–10.00]
Day 5	3.50 [3.00–5.50]	0.38	0.15	[0.02,1.00]	4.00 [2.25–8.00]	0.53	0.11	[0.02,1.00]
1 Month	6.00 [2.00–7.75]				2.50 [0.00–5.50]
IAPS Unpleasant EPN
Baseline	6.525 [6.348–6.787]
Day 5	5.751 [5.139–5.856]	0.01	0.84	[0.76,1.00]
1 Month	3.25 [3.247–4.348]
IAPS Pleasant EPN
Baseline	6.127 [5.946–6.298]
Day 5	5.19 [5.087–5.229]	0.25	0.28	[0.04,1.00]
1 Month	5.300 [3.685–5.731]
IAPS Neutral EPN
Baseline	6.216 [5.740–6.319]
Day 5	6.164 [4.529–6.823]	0.07	0.52	[0.36, 1.00]
1 Month	4.052 [3.74–55.002]

Notes: HD-tDCS, High-Definition Transcranial Current Stimulation; HD-tACS, HD Transcranial Alternating Current Stimulation; PANSS, Positive and Negative Syndrome Scale; SSVEP, Steady State Evoked Potential; GAF, Global Assessment of Functioning; MADRS, Montgomery–Åsberg Depression Rating Scale; IAPS, International Affective Picture System; EPN, Early Posterior Negativity; IQR, Interquartile Range. Statistics reported here include individuals with imputed values for follow-up visits